Multiomics profiling Identifies MCMBP as a prognostic biomarker and a potential immune-related target in pancreatic ductal adenocarcinoma via the JAK–STAT3 pathway. The gene discussed is STAT3; the disease is pancreatic ductal adenocarcinoma.